US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Release time：2024-05-21 21:35:07 Source：Cosmic Chronicle news portal
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
- Previous：Norwegian Cruise Line, Wix.com rise; Cushman & Wakefield, Target fall, Monday, 5/20/2024
- Next：Sophie Morgan suddenly quits ITV show Loose Women as she reveals plans for emigration
Related articles
- Election 2024: Biden and Trump bypassed the Commission on Presidential Debates
- Xi Sends Condolences to Iranian President over Serious Terror Attacks
- Quakes leave 1.5 mln people homeless in Türkiye: UN
- China launches satellite to monitor marine, space environments
- Flight attendant reveals why plane passengers should NEVER fall asleep before take off
- IAEA chief calls for "maximum restraint" over Zaporizhzhia attacks
- Xi, Biden Exchange Congratulations on 45th Anniversary of Diplomatic Ties
- World Insights: WTO members confront U.S. abuse of security exception for protectionist purpose
- Auburn running back Brian Battie on ventilator after weekend shooting in Florida, coach says
- Chinese FM discusses progress of outlook on peace, development in Horn of Africa
- Ricky Stenhouse punching Kyle Busch could lead to suspension
- China launches satellite to monitor marine, space environments
- CPC Leadership Hears Work Reports
- To invest in China is to win the future: spokesperson
- Shooting injures 2 at Missouri high school graduation ceremony
- Chinese women's national football team seeks head coach
- UN urges trillions in investments to salvage global goals
- Sudanese army says will help evacuate foreign nationals
- Kate Hudson hits the stage to debut songs from her new album Glorious at star
- Imposing travel restrictions for China arrivals scientifically unjustified: ACI EUROPE
Random recommendation
- Copyright © 2024 Powered by US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition ,Cosmic Chronicle news portal sitemap